Brief: Mezzion Pharma lowers exercise price of second series bonds with warrants to 25,500 won/share
07/03/2017 02:53
March 7 (Reuters) - Mezzion Pharma Co Ltd 140410.KQ :
* Says it lowered exercise price of second series bonds with
warrants to 25,500 won/share from 30,000 won/share, effective
March 5
Source text in Korean: https://goo.gl/rkc1KO
Further company coverage: 140410.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Mezzion Pharma
See all newsBrief: Mezzion Secures Strategic Financing To Support Advancement Of Global Phase 3 Fuel-2 Trial In Fontan Patients
Brief: Mezzion Reports Pre-Ind FDA Feedback On The Development Of Udenafil In Adpkd
Brief: Mezzion Pharmaceuticals Appoints Ridwan Shabsigh As President & Chief Operating Officer
Brief: Mezzion Pharmaceuticals Reaches Key Enrollment Milestone In World's Largest Fontan Clinical Trial
Brief: Mezzion Pharmaceuticals Announces Dr Rahul Rathod As Global Principal Investigator For The Confirmatory Pivotal Phase 3 Trial FUEL-2